Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-05-21 @ 11:17 AM
Study NCT ID:
NCT01689220
Status:
COMPLETED
Last Update Posted:
2014-09-04
First Post:
2012-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea
Sponsor:
Solasia Pharma K.K.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Peripheral T-cell Lymphoma | View |
Keywords: